US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time By a narrow vote of 50-46, the Senate has confirmed Robert Califf to run the FDA. Benzinga · Feb 16, 2022
Senate confirms Robert Califf to become Biden’s FDA commissioner WASHINGTON — The Senate on Tuesday confirmed Robert Califf to lead the Food and Drug Administration, 50-46, a much narrower vote than when he previously held the position during the Obama administration, though many thought the latest vote could be even closer. Tribune News Service · Feb 15, 2022
Senate confirms Robert Califf as FDA commissioner The agency has been without a permanent leader for more than a year. Axios · Feb 15, 2022
Senate confirms Califf to become Biden's FDA commissioner - Roll Call Six Republicans voted Tuesday to confirm FDA nominee Robert Califf, who had seen opposition from pockets of the Democratic caucus. Roll Call · Feb 15, 2022
Jury finds New York Times did not defame Sarah Palin – as it happened Former Republican vice-presidential nominee sued the newspaper in 2017 claiming an editorial damaged her career The Guardian - US · Feb 15, 2022
Senate sets up Califf confirmation vote with narrow procedural win - Roll Call The nominee to lead the FDA, Robert Califf, survived a Senate procedural vote Monday with the help of five Republicans. Roll Call · Feb 14, 2022
FDA's agenda in limbo as Biden's nominee stalls in Senate President Joe Biden’s pick to lead the powerful Food and Drug Administration has stalled in the narrowly divided Senate The Independent UK · Feb 9, 2022
Wyden probes FDA nominee’s views on accelerated drug approvals WASHINGTON — Senate Finance Chair Ron Wyden, D-Ore., is pressing the White House’s nominee to lead the Food and Drug Administration, Robert Califf, to pledge to crack down on drugmakers’ use of fast-track approval pathways as the nominee seeks the chairman’s support. Tribune News Service · Feb 7, 2022
Wyden probes FDA nominee's views on accelerated drug approvals - Roll Call Support from Wyden could be crucial to Robert Califf's FDA confirmation amid concerns from other Senate Democrats. Roll Call · Feb 7, 2022